The course was developed with RCVS Leadership and Inclusion Manager, Gurpreet Gill (pictured), and aims to increase self-awareness of unconscious bias, explore strategies to reduce it, and promote equity, diversity, and inclusion in the workplace.
Gurpreet said: “Unconscious bias is an area that some within the professions may not be familiar with and so this course provides an overview of unconscious bias and its impact in the workplace.
“We also explore strategies that we can all apply to help reduce unconscious bias.
"This is important in helping to achieve fairer and more equitable working environments, and I’d encourage any veterinary professional, whatever your role, to undertake the course.”
The course is accessible free via the RCVS Academy, and takes about an hour and three quarters to complete,
https://academy.rcvs.org.uk
Whilst there is extensive research into the mental health and wellbeing of veterinary surgeons and veterinary students, far less research has been conducted on this topic with VNs.
The researchers say that despite similarities with vets, the differences in the history, context, education paths, and responsibilities between the professions necessitate a separate study of factors that may have a negative impact on veterinary nurses.
The survey is part of ‘Nursing Matters’, a two-year mixed-methods project, led by the RVC’s Dr Tierney Kinnison, Lecturer in Veterinary Education, and Dr Jackie Cardwell, Associate Professor in Epidemiology, which will attempt to benchmark the profession's mental health and wellbeing, as well as exploring the factors that may lead to poor mental health.
The study aims to identify issues relating to the workplace or educational institutions that can be changed to support VN wellbeing, and to inform the development of supportive and effective clinical teams.
Dr Tierney Kinnison, project leader and Lecturer in Veterinary Education at the Royal Veterinary College, said: “Veterinary nurses are key members of the veterinary clinical team and have received less attention than veterinary surgeons in mental health research to date.
"Responses from any RVN or SVN in the UK, whether they have been directly affected by mental health challenges or not, will be very useful for this research.”
https://rvc.onlinesurveys.ac.uk/nursing-matters
The new product contains astaxanthin (an anti-oxidant), fucoidan (a fucose-rich, sulfated polysaccharide) and indigo (a deodorant), which together are claimed to fight against gum infections, deodorise the mouth, and reduce the build-up of plaque and tartar.
Bob Ferguson, Commercial Lead for Accord Animal Health said: “We are excited to bring to the UK and Ireland market, Vivinicord Chews, a novel combination of natural ingredients designed to aid pet owners support their dogs’ oral health.
"Dental disease and associated infections are such a huge issue for vets and owners, we believe Vivinicord Chews can be a valuable part of the solution.
“Vivinicord Chews will only be available for owners to buy from their local veterinary practice, supporting our mission of building a sustainable partnership with our veterinary customers.”
Vivinicord comes in packs of 30 chews with a shelf life of 24 months.
For further info or stock enquiries, contact: info@accord-animalhealth.com / 01271 385 200
Henry won the title in recognition of his work tackling bird flu, as the outbreak of this devastating disease spread across the country this summer.
A total of 140 nominations were received for this year’s Zoetis-sponsored award, which celebrates vets who have made a significant impact in the first stages of their professional career.
The judging panel comprised BVA President Anna Judson, Royal College of Veterinary Surgeons (RCVS) President Sue Paterson, National Veterinary Lead Ruminant and Equine at Zoetis UK Ally Ward, and last year’s award winner vet Hannah Hunt.
In addition to his work tackling bird flu, the judges also acknowledged Henry’s role in encouraging other young vets to join the poultry industry.
After graduating from the Royal Veterinary College (RVC) in 2018, he began working at Crowshall Veterinary Services, Norfolk, providing dedicated consultancy and Official Veterinarian (OV) provision to the poultry/gamebird industry across Great Britain and internationally.
This has seen him working through the recent bird flu outbreaks, holding multiple OV panels, and preparing for export changes associated with Brexit.
Henry is also a mental health first aider and trustee of regional rural mental health charity You Are Not Alone (YANA), deputy rotation lead for the new RVC poultry rotation, which takes its first students in 2024, and is also co-lead of his practice green group through which he has steered his practice to the top Green accreditation for sustainability with Investors in the Environment.
In his role as external lecturer for the RVC, Henry provides opportunities to engage with avian population medicine for new members of the profession.
Henry said: “To be named BVA Young Vet of the Year is a huge honour and it means all the more having heard about the outstanding work, dedication and skills of the other two finalists.
I’m delighted that after a challenging few years the poultry sector has been highlighted tonight, as all those involved have worked tirelessly to overcome the largest animal health outbreak the UK has experienced in recent times - I hope that winning this award will encourage more young vets to consider joining us in the poultry sector.
"It’s extremely rewarding work.”
Henry was shortlisted alongside vet Rebecca Hampson, who co-founded animal welfare charity Veterinary Education Malawi, and equine vet Camilla Church, who set up her own practice, Perth Equine Vets.
BVA President Anna Judson said: “The standard of nominations this year was outstanding. It sounds cliché, but we really did have our work cut out when choosing the finalists.”
Photo: Young Vet of the Year Henry Lamb with finalists Rebecca Hampson, BVA President Anna Judson and Camilla Church.jpg
The group will also be supporting members in how to reflect on their CPD as a way of consolidating learning, and considering plans for how the benefits of CPD and the VetGDP can be communicated to the professions.
RCVS Council member Dr Olivia Cook MRCVS will be chairing the group.
She said: “The Engagement Group has been set up in recognition that, although the majority of the professions are engaged with meeting their CPD requirements and completing the VetGDP, there are still those who feel confused about the requirements or remain uncompliant for other reasons, and we would like very much to help them.
“Therefore, this is an exciting opportunity for anyone who wants to play an active part in advancing veterinary standards by ensuring that as many members of the professions as possible have the benefits of lifelong learning in their own practice and their ongoing work for animal health and welfare. In doing so they will help grow public confidence in the professions.
“From the VetGDP perspective, we’re particularly keen that there’s a strong peer-to-peer element, so that those who are doing the VetGDP, or have just recently completed it, are using their recent experience and understanding to evolve the policy and drive engagement.”
Applicants who are interested will have until Friday 30 August to apply to become members of the CPD and VetGDP Engagement Group and are invited to send a concise email to CPD@rcvs.org.uk explaining their experience and how they feel that can contribute to work of the committee.
The new pass offers both physical and virtual tickets so that the practice rota doesn't have to stop any member of the team from attending.
BEVA says the new tickets also offer a saving of up to £113 per vet.
David Mountford, Chief Executive of BEVA said: “We know that not every vet at a practice can attend congress every year because someone is always going to have to stay behind and work.
"So, by offering a mix of physical and virtual tickets in the pass it means those staying at home to look after the practice can still benefit from the live stream as well as the six-month access to all the lectures afterwards.
"Congress always contains plenty of relevant and dedicated content for nurses, so the pass obviously includes nurse tickets too.”
Practice Passes are available for BEVA members in three packages: small (£599), medium (£1,333) and large (£2,666).
Individual early bird BEVA member prices are £499 for vets and £187 for vet nurses for all three days (with concessions available for those in their first three years’ post-graduation or on a lower salary).
Practice Passes and early bird tickets are available to purchase until Monday 1 August 2022.
Day tickets are also available.
Virtual tickets are £199 for vets and £40 for nurses.
For more information, or to book tickets, visit http://www.bevacongress.org
The charity highlights that loneliness affects the mental wellbeing of many in the profession, from locums being away from friends and family, students away from loved ones, those who feel isolated at their practice, and veterinary professionals worried about the lonely farmers they are supporting.
Vetlife Helpline Manager Rosie Allister said: “Every call to Vetlife Helpline is completely confidential and we would never speak or write about them, even anonymised, but we do hear themes around loneliness in our calls.
"It takes courage to acknowledge feeling lonely. There’s a stigma to it, and it’s often trivialised. Saying you’re lonely can feel like disclosing a vulnerability. People feel they need to hide it, to put on a façade.”
The new leaflet encourages those who are experiencing loneliness to open up if they are struggling and gives advice on how it can be combatted.
It can be downloaded here: https://www.vetlife.org.uk/mental-health/loneliness-isolation/
The company says the like-for-like sales increase was at the upper end of its target of between 4% and 8%, and that it continues to see resilience in the veterinary sector, with membership of its Healthy Pet Club preventative healthcare scheme increasing in the year by 19,000 members (an increase of 4.0%) to 489,000.
CVS says its Board decided to enter the Australian marketplace because of its low levels of corporate consolidation, favourable market dynamics and strong similarities with the UK, including highly trained veterinary surgeons, shared language and culture, and the group's experience with UK vets working between Australia and the UK.
Earlier this month, the group signed agreements for the conditional acquisitions of four independent small animal first opinion veterinary practices in Australia: two in Brisbane, one in Queensland and one in Sydney, for an initial consideration of £16.8M.
Two of the acquisitions have now been completed, and the other two are expected to be completed shortly.
The company says it now plans to acquire more Australian practices in major urban conurbations, including Sydney, Melbourne, Brisbane, Perth, Canberra, Newcastle and Adelaide.
Ben Jacklin, Deputy CEO said: "Having worked as a vet in Australia earlier in my career, I know well their high standards of clinical care, and the dedication of highly talented veterinary professionals that work there.
"As a company dedicated to giving the best possible care to animals, I see a fantastic opportunity for us to enter this growing market, with low levels of corporate consolidation, and execute our vision of being the veterinary company people most want to work for.
"I have spent time in Australia over the last 12 months, including meeting some fantastic veterinary practices, and it is clear we have a significant opportunity.
"With the four outstanding practices that are joining us, and a strong pipeline of further acquisition opportunities, I am excited to build a significant CVS business in Australia with the same culture and values that have brought us success in the UK."
The day will be led by Sonya Miles, BVSc CertAVP (ZM), CertAqV, MRCVS, RCVS Recognised Advanced Practitioner in Zoological Medicine and WAVMA Certified Aquatic Species Veterinarian.
Lectures will look at techniques, protocols, potential drug options and combinations as well as blood sampling and hospitalisation techniques in a wide variety of exotic species.
Delegates will also be provided with lecture notes, a CPD certificate, refreshments and lunch, as well as goodie bags provided by sponsors Pinmoore Animal Laboratory Services Limited.
Sonya says the aim of the day is to dispel many myths associated with anaesthetising a wide variety of exotic species, including fish and amphibians, whilst simultaneously providing vets and nurses with the skills to undertake these often challenging and comparatively high-risk anaesthetics.
To book your place or for more information, email: info@justexotics.co.uk or book online at https://justexoticsevents.co.uk/dont-miss-out-on-our-latest-event
The study1 suggests that dogs with uncomplicated diarrhoea do not need antibiotics as part of their veterinary care plans.
The study included a random sample of 894 dogs aged between three months and 10 years old diagnosed with uncomplicated diarrhoea in 2019.
Of these, 355 (39.7%) dogs were prescribed antibiotics, and 539 (60.3%) dogs were not prescribed antibiotics (with or without additional supportive treatment) at first presentation for diarrhoea.
For the analysis, the dogs were balanced for a range of other differences between the groups including age, breed, bodyweight, insurance status, the presence of two or more medical conditions, vomiting, reduced appetite, blood in faeces, raised temperature, duration of diarrhoea, additional treatment prescription and veterinary group.
The researchers say this effectively meant that the only difference between the two groups was that one group received antibiotic treatment while the other did not.
The likelihood of clinical resolution of diarrhoea in the dogs prescribed antibiotics was 88.3%, compared with 87.9% in dogs not prescribed antibiotics.
This tiny difference of 0.4% between the groups was not statistically significant, leading to the conclusion that antibiotic treatment did not cause any beneficial effects in the treatment of uncomplicated diarrhoea in dogs.
Almost nine in 10 dogs with uncomplicated diarrhoea recovered after a single veterinary visit regardless of antibiotic treatment.
As an additional analysis, the study also explored gastrointestinal nutraceuticals (products derived from food sources that aim to restore digestive health such as probiotics and prebiotics) for treatment of uncomplicated diarrhoea in dogs.
Gastrointestinal nutraceutical prescription (with or without other supportive treatment) at first presentation of uncomplicated diarrhoea caused no statistically significant difference in clinical resolution compared to dogs not prescribed gastrointestinal nutraceuticals.
Camilla Pegram, VetCompass PhD student at the RVC and lead author of the paper, said: “This study used an exciting new approach that allowed us to determine ‘cause’ rather than being limited to ‘association’.
"Diarrhoea is a common condition in dogs and is often treated with antibiotics.
"However, this study highlighted that antibiotic prescription at first presentation of diarrhoea caused no difference in clinical resolution.
"Therefore, this arms veterinarians with the evidence-base for restricting antibiotics for uncomplicated diarrhoea in dogs, and owners should be prepared to only have an antibiotic prescription if absolutely necessary.”
Fergus Allerton, project lead for the PROTECT ME guidelines and co-author of the paper said: “Rational antimicrobial use is critical to defend ourselves and our pets against the growing threat from antimicrobial resistance.
"This study provides vital evidence to strengthen recommendations to withhold antibiotics when treating dogs with acute diarrhoea. Knowing that the outcome will be the same without antibiotics should reassure veterinarians to adopt this approach consistently.”
Reference
RCVS Council had introduced temporary guidance allowing the remote prescription of drugs for animals not under care back in March, to ensure that animal health and welfare could be maintained during lockdown without risking the health of veterinary teams or their clients.
Since then, the College has twice extended this guidance, because of the ongoing situation.
However the College says it now recognises that many practices are returning more to 'business as usual' and that the guidance and associated flowchart should be updated according.
Consequently, before deciding to prescribe POM-Vs remotely, the updated guidance now requires veterinary surgeons to first consider whether the animal is already under their care; or, if not, whether it is possible to physically examine the animal in order to bring the animal under their care. If the answer to both questions is ‘no’, POM-Vs may still be prescribed remotely providing the guidelines set out in the College’s coronavirus advice hub are adhered to.
Surprisingly, the College says that its surveys of the profession have thus far identified no immediate safety concerns around remote prescribing.
RCVS President Dr Mandisa Greene, who chairs the Taskforce, said: “The reason for maintaining the possibility of remote prescribing without a physical examination was that we recognised that the current situation is unpredictable, and while the ability for the public to visit practices in person has improved over the last few months, we felt that situations might still arise where that would not be possible, and where access to remote prescribing would be necessary. These could include further local lockdowns, ongoing quarantine arrangements, and the remaining fact that some members of both the veterinary team and the public continue to shield.
“It remains our intention that this guidance will continue to be a temporary measure and may be subject to further extensions or updates given the uncertain nature of the Covid-19 pandemic.”
RCVS Council will review the position on 8 October, with any changes being effective by 1 November at the earliest.
Meanwhile, the RCVS review of ‘under care’ and out-of-hours emergency cover has now resumed, starting with a number of virtual focus groups and consultation with stakeholders within the veterinary and veterinary nursing professions.
The findings from these focus group discussions will then inform a wider survey to be sent to all veterinary surgeons and veterinary nurses in early 2021, along with stakeholder organisations and the animal-owning public. Remote prescribing will continue to form a part of this review.
The course has been made available after its authors, Dr Katherine Wakelin and Sarah Corthorne from the University of Surrey, received a Mind Matters Grant to conduct research which found it improved the mental wellbeing of veterinary professionals.
Katherine and Sarah will also be hosting a webinar from 7pm – 8pm on Tuesday 3rd September to discuss the importance of self-compassion, provide an overview of their research, as well as information on the course itself.
Katherine said: “Our recent randomised control trial has shown the course to significantly improve resilience and self-compassion and reduce rumination and self-criticism amongst veterinarians.
"Therefore, Sarah and I are delighted to now be disseminating the CFT course freely to the veterinary profession, so that as many people as possible are able to benefit from the evidence-based resource.
“Even though our research was conducted on veterinary surgeons, we hope that the course will be useful to all those working in the veterinary team as the content can be applied in a number of contexts.
“Our webinar will explain more about our research, as well as some of the science behind the effectiveness of the course in a veterinary context.
"So, if you are interested in learning more about how CFT may be able to help you and your team, both in a personal and professional capacity, please do come along.”
In order to access the online compassion course, individuals are invited to complete a short questionnaire before and after watching one video (10-15 minutes long) each day for 14 days. The aim of the video intervention is to develop self-compassion skills and reduce self-criticism. This will also allow Katherine and Sarah to evaluate the ongoing impact that the videos are having on those working in the sector.
https://vetmindmatters.org/resources/free-online-compassion-course-for-veterinarian-mental-wellbeing/
The service will be run by Dr Eloise Quince BVetMed CertAVP(SAM-F) PgCertVPS MANZCVS MRCVS and Dr Kate Allgood BVetMed CertAVP(SAM) MRCVS.
The practice says radioactive iodine therapy is the treatment of choice for hyperthyroid cats as it provides a permanent cure in up to 95% of cases.
It is administered by an iodine injection under the skin in a specialised unit by a trained vet and nurse.
The practice says a benefit of RI is that it treats ‘ectopic tissue’ that may be present outside of the thyroid gland, for example in the chest, which is not treated by surgical methods of thyroid removal.
Normal thyroid tissue is also spared, so that there is normal thyroid function post-treatment.
Though some blood tests need to be taken post-treatment, there is no need for ongoing blood samples and the monitoring of the thyroid function once successful treatment has occurred.
Elissa Norman, Clinical Director, who initially developed the idea for the iodine unit said: “The iodine unit first started as a scribble on a piece of paper and a dream of our team back in 2017 and it has taken a huge amount of dedication and effort from a large team of people to get to the point of opening in 2023.
"Radioactive iodine offers a lifetime cure for our hyperthyroid cats and we are delighted to be able to bring this service to the cats of East Anglia.”
To refer a cat patient, vets should email iodine@veterinary-hospital.co.uk.
The company says it is calling for the change after analysing the records of its consultations held during the pandemic and finding that there was a low antibiotic prescribing rate, treatments were effective and no harm was caused.
During the seven months that Vet-AI collected data, from the 1st April to the 31st October 2020, its vets held 21,383 veterinary video consultations, an analysis of which is the subject of a paper published in the RCVS Knowledge journal, Veterinary Evidence1.
78.1% of the consultations were for dogs and 21.9% for cats.
Of the vet-led video consultations completed, 3,541 had medicines prescribed during the consultation.
Some consultations required more than one prescription, which meant a total of 4,282 POM-V medications were prescribed.
Of those, Vet-AI says 0.87% reported a mild adverse effect.
Antibiotics were prescribed in 5.9% of all consultations, 99.3% of which was first line.
Vet AI says follow-up on prescribing was available in 67.7% of cases and 89.4% of all known treatment outcomes were complete or had an expected response to treatment.
Skin problems were the most common body system/disease category seen and prescribed for.
The remaining 17,482 consultations, which did not require a prescription medicine, had resolutions assigned.
They included 959 referrals to an emergency in-person veterinarian visit; 4,852 recommendations to visit a vet in-person; 4,216 alternative products recommended, 6,421 follow-up consultations with the remote veterinary team, and 219 remote laboratory tests.
Samantha Webster MRCVS (pictured right), from Joii Pet Care, said: “Given the clear evidence outlined in this report, we believe the future of veterinary medicine should include remote consultations with remote prescribing where appropriate and regulated.
"We invite the RCVS and other veterinary governing bodies to consider that there is a place for prescribing remotely on an ongoing basis for certain cases under certain conditions, such as a secure video and audio link with clinical record keeping and pharmacovigilance practice.
"A blanket ban is not appropriate with the advance of modern technology."
“Bold steps have been taken in human health, incorporating modern technologies to support both GPs and patients, to great success.
"Our industry could use these learnings to help reduce the current strain and demands on vets across the country where mental health is already a key issue due to increased pressures, under resourcing, and compassion fatigue.
“We feel it’s important to take this approach to reach as many owners and provide professional advice and appropriate treatment on pet health so that those animals that do not necessarily currently receive veterinary care do so, and to bridge the gap wanted by clients.”
Dilaterol is an oral syrup containing 25 mgs/ml clenbuterol hydrochloride, indicated to treat respiratory disease in horses. It causes intense bronchodilation, inhibits histamine release and increases ciliary mucous clearance. It can be used as a frontline or adjuvant therapy.
Dilaterol is administered via food and comes in a 355 ml bottle with a pump dispenser for easy and accurate dosing.
Emma Jennings, Equine Brand Manager at Dechra said: “We are very pleased to have added Dilaterol to our comprehensive range of equine therapies as it is an established and effective treatment for bronchial conditions.
"It is particularly useful in cases of respiratory allergy, bronchospasm and equine asthma and is already regarded as a valuable tool for veterinary professionals."
Dilaterol will be available to order through wholesalers. For more information, visit www.dechra.co.uk.
The courses are designed for self-paced learning and include practical hints and tips for treating common animal health issues in companion animals and livestock.
Small animal topics include cardiology, hypertension, dermatology, behaviour and gastroenterology.
Cattle topics include Q fever, reproduction and mobility.
In swine health, content focuses on respiratory health, neonatal disease and zoonotic conditions.
The Ceva Academy also includes downloadable resources, including practice posters, social media content and owner leaflets.
Dan Cripwell, vet channel marketing and technical manager at Ceva, said: “We have consolidated our portfolio of online learning courses and resources into one multi-species portal to give animal health professionals flexible access to high quality CPD and information in one convenient location.”
https://ceva.vbms-training.co.uk/dashboard
The new service will offer all the chemo and surgical options.
Matthew (pictured right) said: "At Eastcott, we have amazing facilities and staff to care for pets with cancer, so we are proud to launch this comprehensive new oncology service.
"We have a custom-designed chemotherapy room, multiple sterile theatres - including our interventional radiology theatre - and state-of-the-art imaging facilities, with a 64-slice CT scanner and advanced ultrasound equipment.
"We are able to manage the full range of tumour types including maxillofacial tumours, from diagnosis to treatment.
"We use a variety of techniques to allow accurate staging, including minimally invasive biopsy and lymph node harvesting, as well as sentinel lymph node mapping and advanced medical imaging.
"Treatment options include advanced soft tissue surgical oncology and the full range of medical oncology. This may involve standard and metronomic chemotherapy, intracavitary chemotherapy and immunotherapy, such as the melanoma vaccine.
"We pride ourselves on helping owners understand our treatment plan through the whole process and emphasise the importance of making the right decisions to maintain the welfare of our patients.”
For more information, visit www.eastcottreferrals.co.uk.
On day one, Laura Playforth, IVC Evidensia’s Group Quality Improvement Director, will be looking at psychological safety and the adoption of a safety-critical culture in veterinary practice.
Sayaka Okushima from Pride Veterinary Referrals and Sarah Heath, IVC's Director of Sustainability, will be discussing the use of anaesthetic gases and ways to reduce them.
Other talks on day one will include: ‘Vets vs Nurses: Are we Blurring the Lines?’ and ‘The Criminal Underworld and Animal Welfare’.
On the second day, IVC referral clinicians will present lectures on various subjects, from handling emergency situations to mastering diagnostic testing equipment in first opinion practice.
David Owen, a Referral ECC Clinician at Vets Now in Manchester, will be talking about talking about emergency dyspnoea cases and how veterinary colleagues can cope with challenging situations efficiently.
Frances Bird, a European Specialist in Small Animal Surgery at Pride Veterinary Referrals, will be closing out the day with a discussion on treating respiratory disease from a surgeon’s perspective.
For the full programme, visit: https://london.vetshow.com/conference-programme?&filters.LOCATION=63903&searchgroup=ADD5CDE8-conference-programme-2023
The Association says it delayed this decision as late as possible, and whilst the most recent government advice does not prohibit large public gatherings, it recognises the importance of personal safety for Congress attendees and the need to support the profession in preserving business continuity, maintaining client services and protecting animal welfare.
Amanda Stranack, BSAVA CEO, said: "As the situation continues to escalate, the government have given a clear steer that they expect more stringent controls to come into force in the coming weeks. With Congress now only a few weeks away, we want to give all our attendees as much notice as possible, both to ensure peace of mind, and to give people adequate time and flexibility to change their plans.
"BSAVA recognises the pressures the current situation brings to bear on the veterinary community and in making this difficult decision, has the interests of the profession first and foremost in its mind.
"We would thank all those who have worked hard over the past two years to contribute to the development of Congress, a huge amount of effort goes into preparations from BSAVA volunteers, Congress participants and our staff."
Sue Paterson, BSAVA President, said: "It is with great regret that we have made the difficult decision to cancel Congress, which has taken place annually for more than 60 years. Congress is an incredibly important event in the veterinary calendar, and we were all looking forward to an inspiring agenda and saying a fond farewell to the city that has made Congress such a great success over so many years. The health and wellbeing of our attendees is of utmost importance to us, and whilst we are sorry to be making this decision, we are confident it is the right one."
BSAVA says it is aware of the impact that cancelling will have on many delegates' CPD hours, so it is now looking at other ways it can deliver Congress lectures and podcasts.
Sue added: "Whilst we won’t be able to deliver the full Congress programme, we will be working with our speakers to capture as many lectures as we can to make content available online."
The company says the new test overcomes a major shortcoming in faecal egg counts: that they can only detect the presence of egg-laying adult worms. The new test, by contrast, can detect all stages of the small redworm life cycle, including the important encysted larval phase.
ADB says the new test will help protect the effectiveness of moxidectin, the only dewormer which is capable of eliminating the encysted stages and against which widespread resistance is not thought to have developed.
Whereas before, routine winter treatment was needed to target the encysted phase, this new test means the drug can be kept for when it is really needed, which will help prevent the development of resistance. ADB says it will also be of great value to equine vets in making differential diagnoses.
The blood test was developed by Prof Jacqui Matthews’ group at the Moredun Research Institute (MRI), with funding from The Horse Trust. She said: "It is great to see the commercialisation of this much-needed test to support sustainable worm control in horses. The test fills an important gap in our diagnostic toolbox and will enable horse owners to work with their veterinarians in targeting anthelmintic treatments against cyathostomin infections and hence help protect these important medicines for the future."
Dr Corrine Austin from ADB said: "ADB is now developing laboratory ELISA kits to enable independent veterinary laboratories to conduct blood testing; these kits are expected to reach market during 2020. Research into the saliva-based test is ongoing and is expected to be commercialised several years from now."
Veterinary practices can contact ADB at info@austindavis.co.uk to register interest in the diagnostic test service.
The talk, by Stephanie Sorrell, Director of The Mindful Vet, will provide insights and tips on how to support staff, promote wellbeing and reduce the stigma associated with mental health in the workplace.
Hillary Noyes, Hill’s Veterinary Affairs Manager, UK & Republic of Ireland said: “Following an unprecedented two years the veterinary profession is still hugely affected by the pandemic with long working hours and limited staff leading to burnout and increased stress for many. “We hope this webinar will raise awareness of this prevalent issue, highlight the importance of burnout awareness and produce valuable insights into recognising the early signs, so that practices are equipped to tackle the crisis.”
To register for the webinar, visit: https://veterinarywebinars.com/register/hills/prevent-and-manage-burnout/
Dechra says Equisolon is the only registered oral prednisolone powder that alleviates the inflammation and clinical parameters associated with severe equine asthma, previously known as recurrent airway obstruction (RAO).
Equisolon Jar contains 180g of powder and comes with a measuring spoon.
One scoop is enough to treat 150kg bodyweight at a dose of 1mg/kg and therefore one jar can treat a 600kg horse for 10 days.
Equisolon was previously available as a box of 10 x 9g pre-measured sachets with one sachet sufficient to treat a 300kg horse and a box contained enough sachets to treat a 600g horse for five days.
Alana McGlade, national sales manager at Dechra said: “The addition of Equisolon Jar to the Equisolon range provides vets with the flexibility to choose between a jar featuring a convenient measuring spoon and a box of easy to dose pre-measured sachets
www.dechra.co.uk/products/horse/prescription
Duncan makes three requests of the UK Government:
The first is to make changes to encourage more overseas vets, and specifically the return of EU vets.
The second is to increase funding for UK universities to provide veterinary courses.
The final request is to update the regulatory framework to enable veterinary nurses to expand their role.
Full article: https://ivcevidensia.co.uk/News/duncan-phillips-time-to-overhaul-vet-support
Ceva says the new product is the fruit of research into the composition of the main feline pheromones which pass through the incisive ducts to the Vomeronasal Organ (VNO), which in turn led to the discovery of a new pheromone complex which 'provides an enhanced message of social confidence and safety in the cat’s environment by conveying more impactful messages to it'.
According to the company, Feliway Optimum helps cats with more signs of stress, in more situations and calms cats better than ever. The product is proven to help with more stress-related signs faster than existing pheromones, with all signs of stress showing continuous improvement until day 28 of use and are visible from day 71. These include scratching, urine spraying, multi-cat tensions and conflicts and changes and fears.
Feliway Optimum is available as a plug-in diffuser with 30-day refills.
Abigail King, senior behaviour product manager at Ceva Animal Health said: "We have led the way with research for over 20 years with Feliway Classic and Feliway Friends, but it is now time to go that step further.
"Feliway Optimum is an extremely exciting addition to the range which will help solve all common signs of stress to provide enhanced serenity in a household.
"Nearly 60 per cent of cats show visible signs of stress2 and Feliway Optimum will really help combat this with an over 70% reduction”.
There is a webinar about the new product, presented by Professor Patrick Pageat and Dr Andy Sparkes, which is available by emailing Ceva.
For more information, visit www.feliway.com/uk, call Ceva on 01494 781510 or email cevauk@ceva.com.
References
IVC's existing Pet Health Club includes vaccinations, flea and worm treatments, microchipping, health checks and a variety of discounts.
IVC says the new tier, Pet Health Club Plus, has been introduced to encourage owners to bring their pet in early, meaning problems can be diagnosed more quickly and therefore improve the welfare outcome of the pet.
It is also designed to support owners by spreading the cost of their pet’s healthcare.
25,000 pet owners have already joined Pet Health Club Plus, which costs £27.99 for cats and £29.99 for dogs, and it is now being pushed with a national TV advertising campaign which will run till the end of the year.